Literature DB >> 34263161

Intranasal Corticosteroids: Patient Administration Angles and Impact of Education.

Sara Treat1, Charles S Ebert1, Zainab Farzal1, Saikat Basu1, Adam M Zanation1, Brian D Thorp1, Julia S Kimbell1,2, Brent A Senior1, Adam J Kimple1,2.   

Abstract

INTRODUCTION: Intranasal corticosteroids sprays (INCS) are first line treatment for allergic rhinitis and are frequently used for chronic rhinosinusitis. Improperly aiming INCS increases the risk of epistaxis and may decrease the efficacy of the medication. The goal of this study was to determine how patients position INCS for drug delivery and if verbal or written instructions improve their positioning.
METHODS: Patients in rhinology clinics were photographed while administering a generic spray bottle. The angle of the spray bottle relative to the patients' head and a fixed background was determined.
RESULTS: A total of 46 participants were included. The average spray angle for the right naris was 10.1° towards the septum and 67.2° below the Frankfurt Horizontal plane. The average spray angle for the left naris was 4.5° towards the septum and 62.2° below the Frankfurt horizontal plane. The angle of the spray bottle ranged from 50° toward the septum to 43° away from the septum. Only 8 patients aimed away from the septum for both nares. Patients who recalled receiving verbal and written instructions aimed the INCS bottle at the lateral wall and inferior turbinate in contrast to patients who only received one form of instruction or no instructions.
CONCLUSIONS: Most patients (83%) incorrectly aim INCS when compared to current guidelines. There was statistically significant improvement in the positioning of patients who reported receiving both verbal and written instruction; however, this study highlights a greater need for patient education.

Entities:  

Keywords:  allergic rhinitis; chronic sinusitis; intranasal corticosteroids; patient education

Year:  2020        PMID: 34263161      PMCID: PMC8276915          DOI: 10.4193/rhinol/20.070

Source DB:  PubMed          Journal:  Rhinol Online        ISSN: 2589-5613


  22 in total

Review 1.  Local and systemic safety of intranasal corticosteroids.

Authors:  J Sastre; R Mosges
Journal:  J Investig Allergol Clin Immunol       Date:  2012       Impact factor: 4.333

2.  The 'best method' of topical nasal drug delivery: comparison of seven techniques.

Authors:  P Merkus; F A Ebbens; B Muller; W J Fokkens
Journal:  Rhinology       Date:  2006-06       Impact factor: 3.681

3.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 4.  Epidemiology of allergic rhinitis.

Authors:  James W Mims
Journal:  Int Forum Allergy Rhinol       Date:  2014-09       Impact factor: 3.858

Review 5.  Contemporary Use of Corticosteroids in Rhinology.

Authors:  Alexander Karatzanis; Alkiviadis Chatzidakis; Athanasia Milioni; Stephan Vlaminck; Hideyuki Kawauchi; Stylianos Velegrakis; Emmanuel Prokopakis
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.806

6.  Understood? Evaluating the readability and understandability of intranasal corticosteroid delivery instructions.

Authors:  Saangyoung E Lee; William C Brown; Mark W Gelpi; Adam J Kimple; Brent A Senior; Adam M Zanation; Brian D Thorp; Charles S Ebert
Journal:  Int Forum Allergy Rhinol       Date:  2020-04-13       Impact factor: 3.858

Review 7.  Steroids in otolaryngology.

Authors:  Daron Cope; Ronaldo Bova
Journal:  Laryngoscope       Date:  2008-09       Impact factor: 3.325

8.  Deviated nasal septum hinders intranasal sprays: a computer simulation study.

Authors:  D O Frank; J S Kimbell; D Cannon; S S Pawar; J S Rhee
Journal:  Rhinology       Date:  2012-09       Impact factor: 3.681

9.  Numerical evaluation of spray position for improved nasal drug delivery.

Authors:  Saikat Basu; Landon T Holbrook; Kathryn Kudlaty; Olulade Fasanmade; Jihong Wu; Alyssa Burke; Benjamin W Langworthy; Zainab Farzal; Mohammed Mamdani; William D Bennett; Jason P Fine; Brent A Senior; Adam M Zanation; Charles S Ebert; Adam J Kimple; Brian D Thorp; Dennis O Frank-Ito; Guilherme J M Garcia; Julia S Kimbell
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 10.  Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.